If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study

Maniscalco, G. T., Saccà, F., Lanzillo, R., Annovazzi, P., Baroncini, D., Binello, E., Repice, A., Perini, P., Clerico, M., Mataluni, G., Bonavita, S., La Gioia, S., Gutierrez, L. P., Laroni, A., Frau, J., Cocco, E., Torri Clerici, V., Zarbo, I. R., Sartori, A., Signoriello, E. & 18 others, Rasia, S., Cordioli, C., Stromillo, M. L., Cerqua, R., Pontecorvo, S., Di Sapio, A., Grasso, R., Barone, S., Lavorgna, L., Barrilà, C., Landi, D., Russo, C. V., Frigeni, B., Ippolito, D., Turano, G., Carmisciano, L., Sormani, M. P. & Signori, A., Jul 2020, In : Multiple Sclerosis and Related Disorders. 42, 102059.

Research output: Contribution to journalArticle

Impact of treatment on cellular immunophenotype in MS: A cross-sectional study

Cellerino, M., Ivaldi, F., Pardini, M., Rotta, G., Vila, G., Bäcker-Koduah, P., Berge, T., Laroni, A., Lapucci, C., Novi, G., Boffa, G., Sbragia, E., Palmeri, S., Asseyer, S., Høgestøl, E., Campi, C., Piana, M., Inglese, M., Paul, F., Harbo, H. F. & 3 others, Villoslada, P., Kerlero de Rosbo, N. & Uccelli, A., May 1 2020, In : Neurology(R) neuroimmunology & neuroinflammation. 7, 3

Research output: Contribution to journalArticle

Open Access

Informing MS patients on treatment options: a consensus on the process of consent taking

on behalf of the RIReMS Group, Jan 1 2020, (Accepted/In press) In : Neurological Sciences.

Research output: Contribution to journalArticle

2019

Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

Vanoli, E., Montano, N., De Angelis, G., Badilini, F., Mirabella, M., Bonavita, S., Patti, F., Bianco, A., Sparaco, M., Chisari, C., Laroni, A., Frigerio, F., Bartezaghi, M., Rossi, S., Turrini, R. & Mancardi, G., Oct 15 2019, In : Journal of the Neurological Sciences. 405, 116423.

Research output: Contribution to journalArticle

Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

Vanoli, E., Montano, N., De Angelis, G., Badilini, F., Mirabella, M., Bonavita, S., Patti, F., Bianco, A., Sparaco, M., Chisari, C., Laroni, A., Frigerio, F., Bartezaghi, M., Rossi, S., Turrini, R. & Mancardi, G., 2019, In : Journal of the Neurological Sciences. 405, 116423.

Research output: Contribution to journalArticle

Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: An Italian multicenter study

Annunziata, P., Masi, G., Cioni, C., Gastaldi, M., Marchioni, E., D'amico, E., Patti, F., Laroni, A., Mancardi, G., Vitetta, F. & Sola, P., Jun 22 2019, In : Neurological Sciences. 40, 7, p. 1383-1391 8 p.

Research output: Contribution to journalArticle

Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study

Annunziata, P., Masi, G., Cioni, C., Gastaldi, M., Marchioni, E., D’amico, E., Patti, F., Laroni, A., Mancardi, G., Vitetta, F. & Sola, P., Jul 1 2019, In : Neurological Sciences. 40, 7, p. 1383-1391 9 p.

Research output: Contribution to journalArticle

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Clerico, M., De Mercanti, S. F., Signori, A., Iudicello, M., Cordioli, C., Signoriello, E., Lus, G., Bonavita, S., Lavorgna, L., Maniscalco, G. T., Curti, E., Lorefice, L., Cocco, E., Nociti, V., Mirabella, M., Baroncini, D., Mataluni, G., Landi, D., Petruzzo, M., Lanzillo, R. & 8 others, Gandoglia, I., Laroni, A., Frangiamore, R., Sartori, A., Cavalla, P., Costantini, G., Sormani, M. P. & Capra, R., Jan 1 2019, (Accepted/In press) In : Neurotherapeutics.

Research output: Contribution to journalArticle

Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey

Lavorgna, L., Esposito, S., Lanzillo, R., Sparaco, M., Ippolito, D., Cocco, E., Fenu, G., Borriello, G., De Mercanti, S., Frau, J., Capuano, R., Trojsi, F., Rosa, L., Clerico, M., Laroni, A., Morra, V. B., Tedeschi, G. & Bonavita, S., Mar 1 2019, In : Journal of Neurology. 266, 3, p. 707-716 10 p.

Research output: Contribution to journalArticle

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): A randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

Uccelli, A., Laroni, A., Brundin, L., Clanet, M., Fernandez, O., Nabavi, S. M., Muraro, P. A., Oliveri, R. S., Radue, E. W., Sellner, J., Soelberg Sorensen, P., Sormani, M. P., Wuerfel, J. T., Battaglia, M. A., Freedman, M. S., Bonetti, B., Rush, C., Herrera, C., Ramo Tello, C., Miller, D. & 23 others, Szwajcer, D., Strunk, D., Wall, D., Aguera-Morales, E., Rohde, E., Dazzi, F., Comi, G., Martino, G., Izquierdo Ayuso, G., Rabinovitch, H., MacLean, H., Marriott, J., Racosta, J., Arab, L., Gimona, M., Introna, M., Blinkenberg, M., Aghdami, N., Ali, R., Vosoughi, R., Nicholas, R., Marrie, R. A. & Karimi, S., May 9 2019, In : Trials. 20, 1, 263.

Research output: Contribution to journalArticle

Open Access

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study

the i-MuST study group, Oct 1 2019, In : Journal of Neurology. 266, 10, p. 2440-2446 7 p.

Research output: Contribution to journalArticle

2018

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study

Saccà, F., Lanzillo, R., Signori, A., Maniscalco, G. T., Signoriello, E., Lo Fermo, S., Repice, A., Annovazzi, P., Baroncini, D., Clerico, M., Binello, E., Cerqua, R., Mataluni, G., Bonavita, S., Lavorgna, L., Zarbo, I. R., Laroni, A., Rossi, S., Pareja Gutierrez, L., La Gioia, S. & 19 others, Frigeni, B., Barcella, V., Frau, J., Cocco, E., Fenu, G., Torri Clerici, V., Sartori, A., Rasia, S., Cordioli, C., Di Sapio, A., Pontecorvo, S., Grasso, R., Barrilà, C., Russo, C. V., Esposito, S., Ippolito, D., Bovis, F., Gallo, F. & Sormani, M. P., Jan 1 2018, (Accepted/In press) In : Multiple Sclerosis Journal.

Research output: Contribution to journalArticle

Enhancing natural killer cells is beneficial in multiple sclerosis – Yes

Laroni, A., Jan 1 2018, (Accepted/In press) In : Multiple Sclerosis Journal.

Research output: Contribution to journalArticle

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

the Italian Alemtuzumab Study Group, 2018, In : Journal of Neurology. 265, 12, p. 2851-2860 10 p.

Research output: Contribution to journalArticle

Pregnancy decision-making in women with multiple sclerosis treated with natalizumabII: Maternal risks

Portaccio, E., Moiola, L., Martinelli, V., Annovazzi, P., Ghezzi, A., Zaffaroni, M., Lanzillo, R., Brescia Morra, V., Rinaldi, F., Gallo, P., Tortorella, C., Paolicelli, D., Pozzilli, C., De Giglio, L., Cavalla, P., Cocco, E., Marrosu, M. G., Solaro, C., Uccelli, A., Laroni, A. & 6 others, Pastò, L., Giannini, M., Trojano, M., Comi, G., Amato, M. P. & Society, MS. S. G. O. T. I. N., Mar 6 2018, In : Neurology. 90, 10, p. e832-e839

Research output: Contribution to journalArticle